However, there was a statistically significant increase in CD4, CD14, CD68, CD8A, B7-H3, PDL-1, CD19, FOCP3, CD44, and STAT3 protein expression in methylated versus unmethylated GBM tumour core (see Table 2). The gene discussed is CD44; the disease is glioblastoma.